➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKinsey
Moodys
Harvard Business School
Boehringer Ingelheim

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: MARAVIROC


Email this page to a colleague

« Back to Dashboard

Maraviroc

CASRN: 376348-65-1

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Merck
Harvard Business School
McKesson
Medtronic